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ABSTRACT: Knowledge of the nature of bioﬂuids at a crime scene is just as important as DNA test to link the nature of the
bioﬂuid, the criminal act, and the dynamics of the crime. Identiﬁcation of methods currently used for each biological ﬂuid (blood,
semen, saliva, urine) suﬀer from several limitations including instability of assayed biomolecules, and low selectivity and spec-
iﬁcity; as an example of the latter issue, it is not possible to discriminate between alpha-amylase 1 (present in saliva) and alpha-
amylase 2 (present in semen and vaginal secretion. In this context, the aim of the work has been to provide a predictive protein
signature characteristic of each bioﬂuid by the recognition of speciﬁc peptides unique for each protein in a single analysis. A panel
of four protein biomarkers for blood, four for saliva, ﬁve for semen, and two for urine has been monitored has been monitored by
using a single multiple reaction monitoring (MRM)-based method targeting concomitantly 46 diﬀerent peptides. Then, The
optimized method allows four biological matrices to be identiﬁed when present on their own or in 50:50 mixture with another
bioﬂuid. Finally, a valid strategy combining both DNA analysis and liquid chromatographic-tandem mass spectrometric multiple
reaction monitoring (LC-MS-MRM) identiﬁcation of bioﬂuids on the same sample has been demonstrated to be particularly eﬀec-
tive in forensic investigation of real trace evidence collected at a crime scene.
In the last three decades the link between forensic inves-tigations and scientiﬁc disciplines, such as Chemistry and
Biology, has been enormously strengthened by the application of
new tools for a detailed characterization of the crime scene
starting from trace evidence. In particular, DNA testing is funda-
mental to identify the individuals involved in a crime often
leading the investigators to deﬁne a unique genetic proﬁle.1
However, the detection and identiﬁcation of the type and
origin of bioﬂuids at a crime scene are just as important as DNA
test to link the nature of the bioﬂuid, the criminal act and the
dynamics of the crime. For example, blood stains can indicate
some form of physical altercation, whereas detection of semen or
vaginal ﬂuid can indicate the involvement of some form of sexual
encounter or assault. Moreover, identiﬁcation of the speciﬁc ﬂuid
or tissue from which the DNA sample was recovered is
fundamental in correctly reconstructing the criminal event and
the eﬀective role of the donor.
The most common bioﬂuids found at crime scenes are blood,
semen, and saliva, but others such as vaginal ﬂuid, urine, and
sweat can also be found. Each of these ﬂuids has one or more
presumptive tests that are initially used to give some indication as
to the identity of the substance; blood is quickly detected by
means of luminol or benzidine,2 whereas traces of semen, saliva,
sweat, urine, and other biological ﬂuids are detected by ultraviolet
light or by other light sources at speciﬁc wavelengths.3 Conﬁr-
matory tests, based on biochemical, spectroscopic, and
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microscopy methods, and immunochemical techniques, are
necessary to give a legal value to the trace evidence.4−9
However, these identiﬁcation methods suﬀer from several
limitations including instability of assayed biomolecules and low
selectivity and speciﬁcity. As an example of the latter issue, it is
not possible to discriminate between α-amylase 1 (present in
saliva) and 2 (present in semen and vaginal secretion).10Moreover,
biochemical assays are speciﬁc only for one biological matrix and
several cascade tests might then be needed before the biological
nature of a certain stain is uncovered. This is even more chal-
lenging when the sample is a mixture of diﬀerent biological matri-
ces thus greatly increasing the complexity, the cost and the time
of the analytical procedures. Finally, some conﬁrmatory tests
very often cause sample loss and they are not compatible with
downstream individual identiﬁcation by DNA analysis.
For all these issues, forensic science is looking for a universal
conﬁrmatory test for the analysis of unknown stains which will be
able to unambiguously identify the type and nature of any bio-
ﬂuids that might be present at a crime scene. The method should
be applicable to mixtures and, more importantly, should preserve
the samples for subsequent DNA analysis. Since bioﬂuids have
evolved to perform diﬀerent functions, they contain diﬀerent
proteins, or diﬀerent combinations of proteins, providing each
biological matrix with a unique protein signature that can be used
to distinguish among the various bioﬂuids.11−13 Recently,
untargeted proteomics have been introduced for the determi-
nation of biological matrices in forensic science based on the
identiﬁcation of the most prominent proteins present in
bioﬂuids.11,14 However, these methods can give poor or uncer-
tain results when high amounts of non speciﬁc proteins occur in
the samples, i.e. when low amounts of a particular ﬂuid are
present in combination with high amounts of other matrices or
when the sample is contaminated by other tissues.
This Article reports a universal method alternative and com-
plementary to “traditional” tests currently used in forensic
investigation to identify an unknown stain of bioﬂuids occurring
at a crime scene. The method is based on a targeted proteomic
approach that makes use of tandem mass spectrometry in
multiple reaction monitoring (MRM) mode to selectively mon-
itor a number of speciﬁc peptides belonging to proteins biomark-
ers of individual biological ﬂuids. First, the most prominent and
highly speciﬁc protein biomarkers for each biological matrix were
identiﬁed by both conventional LC-MS/MS analyses and com-
parison with literature data. Speciﬁc peptide markers of each
protein were then selected on the basis of their mass spectrom-
etric behavior together with their speciﬁc precursor ion-product
ion transitions as deﬁned by their unique amino acid sequence.
Then, a single MRM method was devised to detect the occur-
rence of the target peptides within the sample leading to the
unambiguous discrimination among the diﬀerent biological
matrices in a single analysis because of its high sensitivity,
selectivity and accuracy. The optimized method was tested and
validated on specimens consisting of four biological matrices
(blood, saliva, semen, and urine), or mixtures of matrices, spotted
on diﬀerent substrates like cloth, wood, plastic, plaster, and
paper. Finally, a combined strategy allowing both DNA analysis
and bioﬂuids identiﬁcation on the same sample was developed
and demonstrated to be eﬀective in forensic investigation by the
analysis of real specimens collected at a crime scene.
■ MATERIALS AND METHODS
Control bioﬂuids (blood, saliva, urine, semen) were provided by
a private chemical laboratory. Guanidine, Tris(hydroxymethyl)
aminomethane hydrochloride, dithiothreitol (DTT), ethyl-
endiaminetetraacetate (EDTA), trypsin, iodoacetamide (IAM),
ammonium bicarbonate (AMBIC), trichloroacetic acid (TCA)
were purchased from Sigma-Aldrich. Bovine serum albumin
(BSA), formic acid (HCOOH), methanol, chloroform, and
acetonitrile (ACN) are from J.T. Baker. Bradford staining solu-
tion was from Bio-Rad. Pipette tips C18 (zip tip) and centrifugal
ﬁlter units were purchased from Merck Millipore.
In-Solution Digestion of Proteins from Biological
Matrices. Diﬀerent protocols were performed to improve the
number of identiﬁed proteins and thus to provide the higher
sequence coverage for blood, urine, semen, and saliva. A protocol
of protein precipitation by using chloroform/methanol/water15
was carried out for each bioﬂuids. After precipitation, protein
concentration was determined by Bradford assay using BSA as
standard.16 Samples were submitted to reduction, alkylation and
tryptic digestion. Samples were dissolved in denaturant buﬀer
(urea 6M, Tris 300mMpH8.0, EDTA 10mM) containing DTT
(10-fold molar excess on the Cys residues) at 37 °C for 2 h and
then iodoacetamide (IAM) was added to perform carboamido-
methylation using an excess of alkylating agent (5-fold molar
excess on thiol residues). The mixture was then incubated in the
dark at room temperature for 30 min. The product was puriﬁed
by chloroform/methanol/water precipitation. Supernatants were
removed and the pellets were dried. Digestion of proteins mix-
ture was carried out in AMBIC 10 mM using trypsin at a 50:1
protein/enzyme mass ratio. The samples were incubated at 37 °C
for 16 h and after acidiﬁcation (10% HCOOH) they were dried.
To eliminate any impurities the samples were suspended in 200 μL
of AMBIC 100 mM, ﬁltrated by centrifugal ﬁlter units (0.22 μm),
and dried in a speed-vacuum concentrator. Finally, samples were
suspended in 20 μL of HCOOH 1% and puriﬁed by reverse
phase chromatography using ZipTip C18 cartridges (Millipore).
Samples were evaporated and suspended in 10 μL of HCOOH
0.1% and analyzed by nanoLC-MS/MS and then by LC-MRM/MS
as described below.
To improve the number of identiﬁed proteins from blood by
LC-MS/MS, a step of depletion of abundant proteins was carried
out using ProteoPrepR 20 Plasma Immunodepletion KitProteo-
prep 20 Plasma Immunodepletion Kit (Sigma-Aldrich, Milan,
Italy) able to deplete 20 highly abundant proteins from human
plasma or serum. Dried extracted proteins were subjected to reduc-
tion, carboamidomethylation, chloroform/methanol/water precip-
itation protocol and tryptic hydrolysis as described above.
Protein precipitation from urine was also performed using cold
acetone followed by the same steps of tryptic digestion as
described above. Cold acetone at−20 °C (400 μL) was added to
urine (100 μL) and incubated at −20 °C for 2 h. After centri-
fugation at 12 000 rpm for 15 min the pellet was collected and
dried under vacuum.
Protein precipitation from semen was also carried out using
TCA. Semen was centrifuged (13 000 rpm, 30 min) to remove
cellularmaterial, and the proteins were precipitated (4 °C, 60min)
using an equal volume of cold TCA at ﬁnal concentration of 10%.
Following further centrifugation (10 000 rpm, 30 min), the
supernatant was removed and the protein pellet washed with
cold acetone (three times) to remove residual TCA.
Therefore, a unique precipitation/sample preparation proce-
dure based on chloroform/methanol/water was adopted for all
the samples because the origin or matrix of casework samples.
Test Specimens. Twenty test forensic samples were
prepared by drying diﬀerent biological ﬂuids (100 μL) or
mixture of them on various substrates: cloth, wood, plastic,
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plaster and paper. Cloths were put directly in a plastic tube while
the samples on the other substrates were recovered by a cotton-
swab (Agilent Technologies, Palo Alto, CA). Samples were
collected in plastic tubes and 2mL of AMBIC 50mMwere added
for 16 h under gentle agitation. Samples were then sonicated
for 20min and submitted to chloroform/methanol/water precip-
itation. After precipitation, reduction, alkylation and tryptic
digestion were performed as previously described. The resulting
peptide mixtures were analyzed by LC-MRM/MS as described
below.
Analysis of Real Samples. Real samples consisting of traces
of unknown biological ﬂuids on cloths, paper and stubs collected
at a crime scene (samples 1, 2, and 3) were provided by RIS
Laboratory in Rome. Samples were treated as described above
(see Test Specimens section) and submitted to tryptic digestion.
Then, gDNA was extracted from the samples using the robotic
platform Qiagen Biorobot EZ1 Advanced XL using the Qiagen
EZ1 DNA Investigator kit.17 The DNA was then washed and
eluted in water. DNA degradation and quantiﬁcation level was
evaluated by multiplex RT-PCR using the Quantiﬁler Trio DNA
Quantiﬁcation Kit (Applied Biosystems, CA, USA)18 on a 7500
Real-Time PCR System (Applied Biosystems). Results showed a
total DNA amount of 0.081 ng/μL for sample 1, 0.71 ng/μL for
sample 2, and 1.05 ng/μL for sample 3. Samples were also tested
for possible DNA degradation showing a good quality with a
degradation index of about 1.0 for all samples.
DNA proﬁling was obtained by multiple ampliﬁcation of 17
polimorphic regions comprising the D3S1358, vWA, FGA,
D8S1179, D21S11, D18S51, TH01, D16S539, D2S1338,
D19S433, ACTBP2 (SE33), D1S1656, D2S441, D10S1248,
D12S391, D22S1045, and Amelogenin STR loci using the
Investigator ES Splex SE Plus Kit Qiagen (Qiagen, Hilden,
Germany).18 Ampliﬁed DNA was analyzed by automated DNA
sequencing on an Applied Biosystems 3500xL Genetic
Analyzer.19−21 Data were collected and elaborated using the
3500 Series Data Collection Software v. 2.0and the GeneMapper
ID-X Software v.1.4 (Life Technologies, Carlsbad, CA, USA).
LC-MS/MS Analysis. Peptide mixture were analyzed by
LC-MS/MS on a 6520 Accurate-Mass Q-TOF LC/MS system
(Agilent Technologies) equipped with a 1200 HPLC system and
a chip cube (Agilent Technologies). After loading, the peptide
mixture (1 μL) was concentrated and desalted at ﬂow rate of
4 μL/min in a 40 nL enrichment column (Agilent Technologies
chip) with 0.1%HCOOHas eluent. The sample was then fraction-
ated on a C18 reverse phase capillary column (75 μm*43 mm in
the Agilent Technologies chip) at ﬂow rate of 400 nL/min, with a
linear gradient of eluent B (0.1% HCOOH in 95% acetonitrile)
in A (0.1% HCOOH in 2% acetonitrile) from 5% to 80% in
50 min. Peptides analysis was performed using data-dependent
acquisition of one MS scan (mass range m/z 300−2400)
followed by MS/MS scan of the ﬁve most abundant ions in each
MS scan. MS/MS spectra were measured automatically when the
MS signal was greater than the threshold of 50000 counts.
Doubly- and triply- charged ions were preferably isolated and
fragmented over singly charged ions. Data were acquired through
Mass Hunter software (Agilent Technologies). The acquired
data, containing MS and MS/MS spectra, were transformed in
.mgf format and used for protein identiﬁcation with a licensed
version of Mascot Software (www.matrixscience.com).
Mascot search parameters included: NCBInr as database;
trypsin as enzyme, allowed number of missed cleavage 3; Homo-
Sapiens as taxonomy; carbamidomethyl, C as ﬁxed modiﬁcations;
oxidation of methionine (oxidation (M));, Gln pyro-Glu
(N-term Q) as variable modiﬁcations; 10 ppm MS tolerance,
0.6 Da MS/MS tolerance and peptide charge, from +2 to +3.
MRM Targeted Proteomic Approach. To build up a
targeted MRM method, Skyline software (3.7, 64 bit version
MacCoss Lab Software, University of Washington, USA) was
used for the in silico selection of peptides with unique sequence
for each selected protein. For each peptide, m/z precursor ion,
m/z product ions and relative collision energy were provided by
Skyline. Peptide mixture was analyzed by LC-MS/MS analysis
using a Xevo TQ-S (Waters) equipped with an IonKey UPLC
Microﬂow Source coupled to an UPLC Acquity System (Waters).
For each run, 1 μL peptide mixture was injected and separated on
a TS3 1.0 mm× 150 mm analytical RP column (Waters, Milford,
MA, USA) at 45 °C with ﬂow rate of 3 μL/min using 0.1%
HCOOH inwater (LC-MS grade) as eluent A and 0.1%HCOOH
in ACN as eluent B. Peptides were eluted (starting 1 min after
injection) with a linear gradient of eluent B in A from 7% to 95%
in 55 min. The column was re-equilibrated at initial conditions
for 4 min. The MRM mass spectrometric analyses were
performed in positive ion mode using a MRM detection win-
dow of 0.5−1.6 min per peptide; the duty cycle was set to
automatic and dwell times were minimal 5 ms. Cone voltage was
set to 35 V.
■ RESULTS
Selection of Protein Biomarkers of Biological Matrices.
Four biological matrices, blood, saliva, urine, and semen, repre-
sentative of bioﬂuids recovered at crime scenes, were analyzed to
identify speciﬁc protein biomarkers candidates for each matrix.
Diﬀerent procedures for sample preparation were investigated
(Material and Methods section). As an example, results obtained
for blood with the only chloroform/methanol/water precip-
itation followed by tryptic hydrolysis, are shown in Table 1 where
GI number, the name of identiﬁed proteins, the number of pep-
tides and the corresponding sequence coverage are reported.
The unsatisfactory number of identiﬁed proteins in the orig-
inal assay severely limited the choice of speciﬁc protein bio-
markers for blood candidates for the MRM method because the
dominant abundance of unselective blood proteins. Thus, a diﬀer-
ent sample preparation procedure was then explored by a deplet-
ion step from the most abundant proteins to improve protein
identiﬁcation (Table 2). A signiﬁcantly higher number of
Table 1. List of the Identiﬁed Proteins Following the
Chloroform/Methanol/Water Precipitation Protocol Applied
to Human Blood Sample
GI number identiﬁcation MascotScore
number of
peptides
sequence
coverage (%)
gi|3212456 chain A, crystal structure
of human serum
albumin
1186 35 24
gi|
90108664
chain A, crystal structure
of lipid-free human
apolipoprotein A-I
602 18 22
gi|2765421 immunoglobulin kappa
heavy chain
192 4 34
gi|28637 alpha-1 antitrypsin 188 5 5
gi|386789 hemopexin precursor 178 7 10
gi|28810 β-2-glycoprotein
apolipoprotein H
160 6 1
gi|4557871 serotransferrin precursor 146 6 5
gi|38026 Zn-α2-glycoprotein 75 2 5
gi|112910 α-2-HS-glycoprotein 71 2 4
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peptides were identiﬁed for each protein leading to a much larger
sequence coverage.
Improved results were also obtained in saliva, semen, and urine
analysis by using the chloroform/methanol/water precipitation
protocol. Table S-1 reports the lists of the diﬀerent proteins
identiﬁed for the other matrices, including the GI number, the
number of peptides and the Mascot score.
Proteins identiﬁed for each bioﬂuids by LC-MS/MS were then
compared with literature data11 to eventually select the most
speciﬁc protein biomarkers for each biological matrix. Following
this procedure, proteins listed in Table S-2 were chosen as
representative for each biological ﬂuid.
Development of MRM Methods Speciﬁc for Each
Biological Matrix and a Single MRM Method for All the
Matrices. A number of unique peptides belonging to the target
proteins characteristic of individual biological matrix were selected
by in silico analysis using the Skyline software that provided the
predicted best transitions and collision energy to generate
maximal fragment intensities. The in silico data of the selected
peptides were then compared with the experimental fragmenta-
tion spectra obtained by the LC-MS/MS analyses. Peptides
deﬁned by Skyline analysis and showing the best signal-to-noise
ratio in the experimental fragmentation spectra were selected for
developing MRM methods for each biological ﬂuid. These
methods contained all the precursor ion−product ions trans-
itions and collision energy associated with the selected peptides
from the deﬁned target proteins constituting the protein
signature of each individual bioﬂuids in Table S-2.
As an example, two peptides from α-globin, three from
β-globin and hemopexin, ﬁve from haptoglobin, and six from
α-2-macroglobulinfor a total of 25 peptides and 106 transitions
were selected to monitor the presence of blood and to build the
MRM method for this biological matrix.
The total ion current chromatogram (A) and the MRM TIC
analysis of the three peptides 132−143, 82−94, and 30−39 from
β-globin (B) are shown in Figure 1. Panel C displays the MRM
TIC chromatogram of the three transitions, m/z 409.72 to
507.29,m/z 409.72 to 604.34, andm/z 409.72 to 719.37, used to
monitor the α-globin (92−98) peptide. The diﬀerent transitions
perfectly coeluted at a retention time of 5.24 min thus indicating
that they belong to the same precursor ion.
SimilarMRMmethods were developed for the other biological
matrices (Table S-2). For urine, as an example, Figure S-1 shows
the total ion current chromatogram (A) and the MRM TIC
analysis of the two peptides (507−605) and (204−211) from
uromodulin (B). Panel C displays the TIC chromatogram of the
three transitions for the uromodulin (204−211) peptide.
The diﬀerent transitions perfectly coeluted at a retention time
of 2.99 min thus indicating that they all originated from the same
precursor ion.
Some of the MRM TIC chromatograms of the selected pep-
tides for the speciﬁc detection of proteins from saliva and semen
were reported in Supporting Information (Figures S-2 and S-3).
Once the optimized MRM methods were developed for each
individual biological ﬂuid, the next step involved the develop-
ment of a single MRM method able to detect all the biological
ﬂuids in a single analysis. For each selected protein biomarker,
all the selected peptide sequences, m/z precursor ion, m/z
product ions and the optimized collision energy were tabulated in
Table S-4.
As the mass spectrometer was able to handle a very large
number of transitions per run, the single MRMmethod was built
up by using a total of 46 peptides and 212 transitions.
Analysis of Test Specimens. For all the test specimen sam-
ples, the MRM chromatograms solely showed the mass tran-
sitions associated with the target peptides belonging to the
speciﬁc proteins constituting the unique signature of the deﬁned
matrix. No transitions related to peptides from proteins
characteristic of other biological ﬂuids were detected for all the
analyzed samples. As an example, Figure 2A shows the MRM
TIC chromatogram of the three transitions, m/z 637.86 to
687.35,m/z 637.86 to 850.42,m/z 637.86 to 949.49,m/z 637.86
to 1048.56, and m/z 637.86 to 1161.64 used to monitor the
β-globin (30−39) peptide form a blood sample spotted on plas-
ter. Panel B showed the corresponding MRM chromatogram for
the (1075−1086) peptide from mucin-6, a protein speciﬁc of
semen, illustrating the absence of any nonspeciﬁc transition of inter-
fering proteins. This result clearly demonstrates that the speciﬁc
signature of blood could be easily monitored whereas no
interference from cross transitions of peptides belonging to other
biological matrices was detected.
Similar results were obtained on all the other spotted samples
and are summarized in Table 3. Each biological matrix could be
unambiguously identiﬁed by the developed MRM method even
on diﬀerent substrates. No cross transitions were observed what-
soever with the exception of urine where peptides from PSA and
PAP proteins, a speciﬁc signature of semen, was also detected.
However, the presence of seminal proteins in urine is somehow
expected and provides further information on the origin of the
sample that was obviously from a male donor.
To test the MRM optimized method capability to unam-
biguously deﬁne the occurrence of individual bioﬂuids when
occurring in a 50:50 ratio mixture, blood−semen, blood−urine,
and semen−urine were spotted onto diﬀerent substrates. The
negative controls, for a total of 5 sample, consisted of the exclu-
sive use of substrates: cloth, wood, plastic, plaster, and paper.
As shown in Table S-5, each individual component of the binary
mixture was unambiguously identiﬁed by the speciﬁc transitions
of the unique peptide signature; whenever urine was present,
speciﬁc peptides from semen proteins were also detected.
Analysis of Real Crime Scene Samples. The developed
procedure was then applied to real samples collected at a crime
scene by the RIS Laboratory in Rome. Samples were prepared
according to the procedure described above and following enzy-
matic hydrolysis, DNA was extracted from each sample
according to the normal procedure performed at the RIS
Table 2. List of the Identiﬁed Proteins Following the
Depletion Step Previous to the Chloroform/Methanol/Water
Precipitation Protocola
GI number identiﬁcation MascotScore
number of
peptides
sequence
coverage (%)
gi|1431650 chain β of hemoglobin 156 6 20
gi|229751 chain α of hemoglobin 138 4 15
gi|3212456 chain A, crystal
structure of human
serum albumin
1995 48 34
gi|
194383506
serum transferrin 1012 34 29
gi|90108664 chain A, crystal
structure of lipid-free
human
apolipoprotein A-I
562 22 27
gi|177870 α-2-macroglobulin 485 17 7
gi|13787109 α-1-antitrypsin 337 12 14
aThe GI number, the number of peptides, the corresponding Mascot
score, and sequence coverage are reported for human blood sample.
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Laboratory. DNA extracts were quantiﬁed, the degradation level
was evaluated and the DNA proﬁling obtained as described in
Materials and Methods section. The resulting genotypic proﬁle
of sample 1 is shown in Figure S-4 and was identiﬁed as a male
genotype proﬁle called “Proﬁle A”. The quality of the data
exceeded the minimum quality requirements established by
Figure 1. Identiﬁcation of all the protein of blood ﬂuid by LC-MS/MS analysis and MRM/MS data of the deﬁned target proteins constituting the
protein signature of blood. Panel A: Total ion current (TIC) as a function of time (min.). LC-MS-MS analysis allowed the identiﬁcation of protein
content on blood tryptic peptide mixture. Panel B: BPI Chromatograms for β-globin 132−143, 82−94, 30−39 peptides eluted at 6.18, 11.46, and 16.91 min,
respectively. Panel C: MRM TIC Chromatograms extracted for α-globin (92−98) peptide. The monitored transitions for this peptide: m/z 409.72 to
719.37, m/z 409.72 to 604.34, and m/z 409.72 to 507.29 are perfectly coeluted at 5.24 min as an unambiguous identiﬁcation of blood detection.
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internal validation procedures for this Lab for comparative proce-
dures to be used for personal identiﬁcation purposes.
Following DNA analysis, the remainder of the samples con-
taining the mixture of tryptic peptides was submitted to the
developed MRM analytical procedure. Figure 3 shows the TIC
analysis of the three peptides 30−39, 82−94, and 132−143 mon-
itored for the human β-globin and two peptides 92−98 and
127−138 monitored for the human α-globin (A). Panel B
displays the MRM TIC chromatogram corresponding to four
transitions, m/z 637.87 to 687.35, m/z 637.87 to 850.42, m/z
637.87 to 949.48, and m/z 637.87 to 1048.55, used to monitor
the β-globin (30−39) peptide. As shown in Table 4, the MRM
analysis was able to unambiguously deﬁne individual protein
component occurring in the diﬀerent samples by their unique
peptide signature even after DNA extraction and analysis.
Therefore, this combined procedure led to both DNA proﬁling
analysis and the unambiguous identiﬁcation of blood indicating
the biological ﬂuid the DNA was collected from.
■ DISCUSSION
Knowledge of the nature of bioﬂuid discovered at a crime scene
can inﬂuence the outcome of a case. Identiﬁcation of a suspect’s
DNA on a victim is quite diﬀerent if it comes from saliva, sug-
gesting intimate contact, wither consensual or forced, or from
blood or seminal ﬂuid, indicating a physical struggle or a sexual
assault. However, this is not always an easy task, since many
bioﬂuid stains are either invisible to the naked eye or similar in
appearance to other ﬂuids or substances. Even when the identity
of a stain may seem obvious to a forensic investigator, absolute
conﬁrmation is necessary to give a legal value to the trace
evidence to either prove or disprove a fact in a lawsuit. This is
especially important with the possible occurrence of mixtures as
single stain could contain multiple bioﬂuids.
Most biochemical and immunologic tests which have been
used for presumptive or conﬁrmatory methods suﬀer from several
limitations leading to sample destruction resulting in sample loss
for subsequent DNA analysis or to incompatibility with down-
stream individual identiﬁcation assays, that is, DNA proﬁling.
Moreover, most of the current methods are designed to detect a
single bioﬂuid forcing the investigators to decide which test to
perform in the presence of a limited amount of sample.
Contrary to DNA, proteins were rarely considered and
scarcely used as sources of useful biological traces in crime scene
investigations. Proteins tend to be less stable than DNA and are
easily degraded making their identiﬁcation by immunological
methods unfeasible. Moreover, the amount of available samples
cannot be ampliﬁed by “PCR-like” procedures thus requiring the
use of analytical techniques with extremely high sensitivity.22
More recently, proteomics strategies have been applied to the
identiﬁcation of bioﬂuids that overcome most of the previous
diﬃculties. In proteomic approaches, proteins are identiﬁed by
their peptide fragments making the degradation no longer a
problem.Moreover, contrary to DNA, proteins are tissue-speciﬁc
providing a unique signature to identify biological tissues and
ﬂuids. Finally, the tiny amount of trace evidence usually recov-
ered at a crime scene is matched by the extraordinary sensitivity
of modern mass spectrometers. Untargeted proteomic approaches
demonstrated to be eﬀective in the deﬁnition of bioﬂuids in
traces from crime scenes by identiﬁcation of speciﬁc proteins
belonging to individual biological sample.5 However, severe limi-
tations in sensitivity, in the analysis of mixed traces and, more
important, in preserving the samples for subsequent DNA ana-
lysis still exist. A recent study has greatly overcome this drawback
by MALD IMS imaging directly on a blood ﬁngermark leaving
the ridge detail completely preserved.10 Despite the fact that the
proposed method is as destructive as the other approaches, the
great compatibility between DNA extraction and MS strategy
protocols allows to limit the destruction of the entire trace
evidence. Indeed, a combined strategy to provide both DNA
analysis proﬁling by RIS laboratory and identiﬁcation of the
Figure 2.MRM/MS analysis of test specimens: blood spotted on plaster. Panel A: MRMTIC Chromatograms extracted for β-globin (30−39) peptide.
The best ﬁve monitored transitions m/z 637.87 to 687.36, m/z 637.87 to 850.42, m/z 637.87 to 949.49, m/z 637.87 to 1048.56, and m/z 637.87 to
1161.64 are reported in ﬁgure eluted at 16.73 min. Panel B: MRM TIC chromatogram extracted for (1075−1086) peptide from mucin-6 a protein
speciﬁc of semen, illustrating the absence of any nonspeciﬁc transition (m/z 785.38 to 960.42, m/z 785.38 to 1057.48, m/z 785.38 to 1307.62).
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corresponding biological ﬂuids on the same sample collected at
real crime scenes has been developed. Samples were deprotei-
nized by treatment with trypsin instead of the commonly used
nonspeciﬁc proteases, that is, Pronase, proteinase K, etc. DNA
was then extracted from the digested samples and analyzed
according to the usual procedure, yielding optimal DNA proﬁles.
Moreover, the proposed bottom-up approach makes this method
valid also on old traces that have undergone degradation. Another
advantage from the current approach is the unambiguous identi-
ﬁcation of all target proteins allowing us to unequivocally
Figure 3.MRM/MS analysis of real crime scene samples after DNA extraction. Panel A: BPI Chromatograms for α-globin 92−98 and 127−138 peptides
eluted at 5.26 and 14.91 min respectively and BPI Chromatograms for β-globin 132−143, 82−94, AND 30−39 peptides eluted at 11.40, 11.50, AND
16.62 min, respectively. Panel B: MRMTIC chromatogram corresponding to four transitions,m/z 637.87 to 687.35,m/z 637.87 to 850.42,m/z 637.87
to 949.48, and m/z 637.87 to 1048.55 perfectly coeluted at 16.59 min, used to monitor the β-globin (30−39) peptide.
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discriminate among the diﬀerent ﬂuids, even in mixture by a single
MRM run of less than 1 h.
Indeed, four proteins, α-globin, β-globin, haptoglobin, and
hemopexin have been selected for blood signature, four for saliva
(α-amylase 1, mucin-5, annexin A1, and cystatin S), ﬁve for
semen (semenogelin I and II, PSA, PAP, and mucin-6) and two
proteins determined for urine (uromodulin and osteopontin).
For each protein biomarker, a number of unique tryptic peptides
(proteotypics) has been selected with the use of bioinformatics
tools and the best precursor ion-fragments transitions employed
to set up a single MRM method able to identify any of the four
bioﬂuids in unknown stains. The MRM LC-MS/MS analysis
recognizes the speciﬁc peptides by their unique transitions. The
identiﬁed proteotypic peptides have been correlated to each set
of selected protein biomarkers that in turn unambiguously
deﬁned the biological ﬂuids under investigation.
The MRM method optimized on pure samples of the four
matrices, blood, urine, semen and saliva, is resulted to have good
speciﬁcity and selectivity for each bioﬂuid with no cross-
contamination observed whatsoever. A single contamination was
detected in the urine samples spotted on diﬀerent surfaces that
showed the occurrence of small amount of seminal ﬂuid.
Table 4. Identiﬁcation of the Biomarker Proteins by MRM Analysis in Three Samples Obtained from RIS Laboratories after DNA
Extraction and Analysisa
peptide sample 1 sample 2 sample 3
blood α Hb K.VGAHAGEYGAEALER.M [16, 30] x
R.VDPVNFK.L [92, 98] x
K.FLASVSTVLTSK.Y[127, 138] x x
β Hb R.LLVVYPWTQR.F [30, 39] x x
K.GTFATLSELHCDK.L [82, 94] x
K.VVAGVANALAHK.Y [132, 143] x
hemopexin R.ELISER.W [82, 87] x
K.VDGALCMEK.S [401, 409] x
haptoglobin K.DIAPTLTLYVGK.K [156, 167] x
R.VMPICLPSK.D [202, 210] x
saliva α amylase R.WVDIALECER.Y [35, 44] x
K.SSDYFGNGR.V [258, 266] x
annexin 1 K.GVDEATIIDILTK.R [58, 70] x
R.SEIDMNDIK.A [303, 311] x
K.ILVALCGGN.- [337, 345] x
MUC 5AC K.GVQLSDWR.D [1335, 1342] x
R.AQAQPGVPLR.E [2999, 3008] x
cystatin S K.QLCSFEIYEVPWEDR.M [115, 129]
R.MSLVNSR.C [130, 136] x
semen MUC 6 K.VTNEFVSEEGK.F [182, 192] x
R.ETDPCSMSQLNK.V [573, 584] x
R.GVLLWGWR.S [646, 653] x
K.VYHLPYYEACVR.D [1075, 1086] x
SEM II K.GHYQNVVDVR.E [217, 226] x
K.DIFTTQDELLVYNK.N [251, 264]
K.ISYQSSSTEER.H [345, 355] x
K.QDLLSHEQK.G [534, 542] x
PSA R.IVGGWECEK.H [20, 28] x
K.HSQPWQVLVASR.G [29, 40] x
R.LSEPAELTDAVK.V [121, 132] x
K.FMLCAGR.W [190, 196] x
PAP R.SPIDTFPTDPIK.E [47, 58] x
K.DFIATLGK.L [185, 192] x
R.ELSELSLLSLYGIHK.Q [236, 250] x
SEM 1 R.LWVHGLSK.E [165, 172] x
K.VQTSLCPAHQDK.L [233, 244] x
K.DVSQSSIYSQTEEK.A [307, 320]
K.GESGQSTNR.E [404, 412] x
urine osteopontin K.QNLLAPQTLPSK.S [51, 62]
R.GDSVVYGLR.S [145, 153]
R.ISHELDSASSEV.- [287, 298]
uromodulin R.STEYGEGYACDTDLR.G [185, 199]
K.VFMYLSDSR.C [356, 364]
K.INFACSYPLDMK.V [420, 431]
R.VGGTGMFTVR.M [449, 458]
R.VLNLGPITR.K [597, 605]
aX is reported when the unique peptides belonging to the target proteins characteristic of individual biological matrix were identiﬁed by MRM analysis.
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However, this presence was somehow expected and contributed
to indicate a male donor. Then in a proof of concept, prepared
test samples consisting of diﬀerent ﬂuids spotted on various
substrates have been analyzed by using the single optimized
MRM method.
The current results demonstrated that the developed strategy
based on the MRM LC-MS/MS method could be a useful sub-
strate in forensic science due to its capability of providing a
universal approach for the identiﬁcation of unknown stains recov-
ered at crime scenes with high selectivity and speciﬁcity.Moreover,
this approach can be carried out on the same samples used for
DNA proﬁling revealing the nature of the tissue or ﬂuid the DNA
had been recovered from.
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